Keywords
Antibiotics
Usage Statistics
How to Cite
Abstract
Antibiotic resistance has become one of the greatest healthcare and therapeutic challenges in hospitals, posing a serious threat to the health of both patients and medical staff (1). As bacteria and other organisms that are capable of resisting antibiotics multiply and spread, treating many hospital-acquired infections becomes increasingly complex and difficult. This phenomenon is exacerbated by the inappropriate and excessive use of antibiotics in hospitals, particularly in intensive care units, leading to severe complications, including mortality caused by drug-resistant infections (2). Microbial resistance can result in prolonged hospitalization time, high treatment costs, and ultimately, death among patients who contract resistant infections. Therefore, identifying and controlling this resistance, especially in hospital settings, requires immediate attention and action. The World Health Organization has recently identified three categories of pathogens, namely: critical, high, and medium priority, according to the need for new antibiotics (3).
References
1. Rodrigues RA, Azevedo CLAP, Djahjah MCR, Pereira TSS. Tubular adenoma of the breast: Radiological and ultrasound findings. Radiol Bras. 2018;51:341-2. [DOI:10.1590/0100-3984.2017.0012]
2. Efared B, Sidibé IS, Abdoulaziz S, Hammas N, Chbani L, El Fatemi H. Tubular Adenoma of the Breast: A Clinicopathologic Study of a Series of 9 Cases. Clin Med Insights Pathol 2018;11:1179555718757499. [DOI:10.1177/1179555718757499]
3. Düşünceli F, Manukyan MN, Midi A, Deveci U, Yener N. Giant Tubular Adenoma of the Breast: A Rare Entity. The Breast Journal. 2012;18:79-80. [DOI:10.1111/j.1524-4741.2011.01186.x]
4. Huang Y, Zhang H, Zhou Q, Ling L, Wang S. Giant tubular adenoma of the accessory breast in the anterior chest wall occurred in a pregnant woman. DiagnPathol. 20154;10:60. [DOI:10.1186/s13000-015-0286-0]
5. Kalipatnapu S, Samuel V, Johnson M, Perookavil Daniel K. A Case Report of a Giant Tubular Adenoma With a Concurrent Fibroadenoma of the Breast. World J Oncol. 2015;6:502-3. [DOI:10.14740/wjon954e]
6. Miller MC, Johnson P, Kim S, Choi L. Tubular adenomas of the breast: a rare diagnosis. BMJ Case Rep. 2018;2018:bcr2018224631. [DOI:10.1136/bcr-2018-224631]
7. Mazingi D, Mbanje C, Jakanani G, Muguti GI, Mandizvidza V, Bopoto S. Maffucci's syndrome in association with giant tubular adenoma of the breast: Case report and literature review. Int J Surg Case Rep. 2019;63:147-52. [DOI:10.1016/j.ijscr.2019.09.012]
8. Chehab J, Montes H, Zabrano M. Giant tubular adenoma of the breast, a rare bening pathology: A case report. Rev Oncol Ecu. 2022;32:122-8. [DOI:10.33821/570]
9. Chang S, Fairweather P, Sivyer P, Bennett I. Giant adolescent tubular adenoma of the breast mimicking giant fibroadenoma: a case report. Int Surg J. 2024; 11:1681-4. [DOI:10.18203/2349-2902.isj20242771]
10. Qasmi G, Rizwan A, Mahmood S, Hammed M, Ejaz R. Giant tubular adenoma of beast in a nulliparous female: A case report. Journal of Allama Iqbal Medical College. 2022;20:4-7. [DOI:10.59058/jaimc.v20i1.15]
11. Sengupta S, Pal S, Biswas BK, Phukan JP, Sinha A, Sinha R. Preoperative diagnosis of tubular adenoma of breast: 10 years of experience. N Am J Med Sci. 2014;6:219-23. [DOI:10.4103/1947-2714.132940]
12. Soo MS, Dash N, Bentley R, Lee LH, Nathan G. Tubular adenomas of the breast: imaging findings with histologic correlation. AJR Am J Roentgenol. 2000; 174:757-61. [DOI:10.2214/ajr.174.3.1740757]
13. Min Y, Bae SY, Lee HC, Lee JH, Kim M, Kim J, et al. Tubular carcinoma of the breast: clinicopathologic features and survival outcome compared with ductal carcinoma in situ. J Breast Cancer. 2013;16:404-9. [DOI:10.4048/jbc.2013.16.4.404]
14. Saimura M, Anan K, Mitsuyama S, et al. Ductal carcinoma in situ arising in tubular adenoma of the breast. Breast Cancer. 2015;22:428-431. [DOI:10.1007/s12282-012-0375-9]
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.